Navigation Links
Study: Patient Harm More Common with Patient-Controlled Pain Medication
Date:12/1/2008

tains a syringe of doctor-prescribed pain medication is connected directly to a patient's intravenous (IV) line. PCA can be used to relieve pain after surgery or for other chronic pain conditions. Harm associated with PCA errors can include respiration suppression, inadequate pain relief and patient death.

Data for the study came from voluntary reports to the United States Pharmacopeia (USP)'s MEDMARX Program, and shows that more than 60 percent of the hospitals anonymously reporting medication errors through MEDMARX had at least one PCA error. The study -- "Medication Errors Involving Patient-Controlled Analgesia" -- is important because preventing PCA errors "would yield substantial gains in patient safety," the authors conclude.

To reduce PCA errors, Dr. Hicks and the co-authors recommend three strategies:

  • Simplify the technical equipment used in PCA. The study shows that the PCA process is heavily dependent on the ability of caregivers to execute sequential tasks successfully, so easy-to-follow setup instructions for equipment could reduce errors. The study urges PCA vendors to look for ways to make it less likely that programming errors will lead to a wrong dose.
  • Use bar codes and an electronic medication administration record to reduce errors that involve the wrong medication. Independent double-checks of the PCA orders, the product and the PCA device settings should be standard practice, the study advises.
  • Ask pharmacists to design easily understood and standardized forms for PCA, and ensure that prescribers use only these standardized forms. These actions would address communication problems that lead to errors and bring regional standardization to the PCA process.

In 2004 The Joint Commission issued a '/>"/>

SOURCE The Joint Commission
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine news :

1. Study: Childhood constipation just as serious as asthma
2. Study: Want to be happier? Be more grateful
3. Study: Smoking Ban Would Help Reduce Heart Attack Admissions
4. New study: A Common Class of GI Medications Reduce Protection Against Heart Attack in Patients Taking Widely Prescribed Cardiovascular Drug
5. University of Illinois - Chicago Study: Raisins Contain Compounds that May Inhibit Cavity-causing Bacteria
6. Geisinger study: Increasing health care value improves health care quality
7. UNC study: Parenting can override effect of genes in how babies respond to stress
8. Study: Delaying evolution of drug resistance in malaria parasite possible
9. U. of Chicago study: More than 10 percent of older Americans suffer mistreatment
10. UNC study: chilling hardship rates among families raising disabled children
11. UNC study: Two-thirds of severe sports injuries to female students due to cheerleading

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/4/2009)... InhibOx, a leading developer of novel and effecti...oined forces with MolPort, an innovator in rare ch... chemical trading platform and builds database of ...his database and its updates to computational chem... virtual screening procedures. Once they identify ...
(Date:12/4/2009)...Plantar fasciitis heel pain affects over two milli... therapy has been cited by the American Academy of...ion. In response to these findings, Orthotics And... therapy systems for plantar fasciitis treatment a...lint therapies. , (PRWEB)...
(Date:12/4/2009)...f., Dec. 4 Herpes zoster, also kno...ve been vaccinated against chicken pox, according ... of the Pediatric Infectious Diseases Journal. ,...tronic health records to identify more than 170,00...pox) vaccine from 2002 to 2008 in Kaiser Permanent...
(Date:12/3/2009)...With a membership increase of more than 15 percent...ly as a milestone in its history, but also as a si...ociations are experiencing a decline in membership...when trade organizations across the nation are suf... unprecedented growth, signaling that physicians s...
(Date:12/3/2009)....J., Dec. 3 The development of Uni...(UMCPP) reached a milestone today with a "topping ...me construction at the new hospital that will repl... ,, (Photo: http://www.newscom.com/cgi-bin/prn...is a steelworkers, tradition in which a steel beam...
Breaking Medicine News(10 mins):Health News:InhibOx and Molport Join Forces to Deliver Integrated Lead Design and Delivery 2Health News:InhibOx and Molport Join Forces to Deliver Integrated Lead Design and Delivery 3Health News:Orthotics And Beyond Introduces Compressive Cold Therapy Products for Plantar Fasciitis Treatment 2Health News:Chicken Pox Vaccine May Also Reduce Risk of Shingles Among Children 2Health News:Chicken Pox Vaccine May Also Reduce Risk of Shingles Among Children 3Health News:Florida Medical Association Marks Record Membership Growth 2Health News:'Topping Out' Ceremony Marks Milestone in Construction of University Medical Center of Princeton at Plainsboro 2Health News:'Topping Out' Ceremony Marks Milestone in Construction of University Medical Center of Princeton at Plainsboro 3Health News:'Topping Out' Ceremony Marks Milestone in Construction of University Medical Center of Princeton at Plainsboro 4
...cardiologist from the University of Alabama, Birmi...bility trial that the drug showed no significant d... users and those taking similar drugs or placebos....t 28,000 patients, contained no evidence that Viox...
...amining the heart and making a correct diagnosis c...er than medical students, residents, and other pra...xamination and in accurately identifying abnormal ...ka M. Vukanovic-Criley, from Stanford University i...
... that smoking and drinking at an early age could l...e adverse effects of tobacco and alcohol has on ou...eading cause of cancer deaths, and doctors general... portal HealthDay News. Researchers led by Dr. ...
...ituminous coal, which is comparable to Jet A or mi...icopter jet engine and can now be used for propell...fuel scientist. // "Because the fuel is 50 p...nce and director of Penn State's Energy Institute....
...port by the UNH scientist, the beginning of 'natur... effect, which is a result of global warming, has ...hereby creating a ripple effect in all the happeni...ther Nature is increasingly getting a jumpstart on...
...an Singh has announced the launch of an ambitious ... five institutions in order to train around 5,000 ...seeks to address the inequalities in healthcare be...ti-disciplinary knowledge through a network of pub...
Other Medicine News:Health News:Could Long Tern Vioxx Users Suffer From Heart Attacks? 2Health News:Jets Can Now Be Propelled By Coal-based Fuel 2Health News:‘Natural Spring’ Starts A Week Ahead Now Than Before: UNH Scienti 2Health News:‘Natural Spring’ Starts A Week Ahead Now Than Before: UNH Scienti 3
(Date:12/3/2009)..., Dec. 3 A genetic varia...ing a potentially life-threatening blood disorder ...chemicals is one of several medical discoveries sc...stics (NYSE: DGX ) will present during the 51st ...g and Exposition, December 5-8, 2009, in New Orlea...
(Date:12/3/2009)...c. 3 BioMed Realty Trust...entered into a new lease with Regeneron Pharmaceut...,000 square feet of additional, newly-constructed ...tview campus in Tarrytown, New York. The new lease...l space was completed approximately two months aft...
(Date:12/3/2009)...OERSHOLM, Denmark and SAN DIEGO, California, Decem...fully Inhibits miR-122, a microRNA Important for,H...y Reducing Hepatitis C,Virus in the Bloodstream in...is C Virus , - SPC3649 Demonstrates Effic...rious Adverse Events in the Treated Animals - Sign...
Breaking Medicine Technology:Quest Diagnostics Reveals New Genetic Discoveries for Testing for Leukemia, Lymphoma and Blood Clotting at 51st ASH Meeting and Exposition 2Quest Diagnostics Reveals New Genetic Discoveries for Testing for Leukemia, Lymphoma and Blood Clotting at 51st ASH Meeting and Exposition 3BioMed Realty Trust Signs New Lease With Regeneron Pharmaceuticals for 131,000 Square Feet at Landmark 2BioMed Realty Trust Signs New Lease With Regeneron Pharmaceuticals for 131,000 Square Feet at Landmark 3New Data Shows Breakthrough microRNA-Targeted Therapy Developed Using Santaris Pharma A/S Proprietary LNA Technology Holds Promise as New Treatment for Hepatitis C 2New Data Shows Breakthrough microRNA-Targeted Therapy Developed Using Santaris Pharma A/S Proprietary LNA Technology Holds Promise as New Treatment for Hepatitis C 3New Data Shows Breakthrough microRNA-Targeted Therapy Developed Using Santaris Pharma A/S Proprietary LNA Technology Holds Promise as New Treatment for Hepatitis C 4New Data Shows Breakthrough microRNA-Targeted Therapy Developed Using Santaris Pharma A/S Proprietary LNA Technology Holds Promise as New Treatment for Hepatitis C 5Astellas and The National Science Teachers Association Announce 2009 Class of Local Science Educators 57780 1Astellas and The National Science Teachers Association Announce 2009 Class of Local Science Educators 57780 2Astellas and The National Science Teachers Association Announce 2009 Class of Local Science Educators 57780 3Thomson Reuters Launches Thomson Pharma Partnering Forecast 57778 1Thomson Reuters Launches Thomson Pharma Partnering Forecast 57778 2Nuvilex Inc Announced that Reme Flu 28TM 29 will Incorporate Proprietary Syn X9 28TM 29 Delivery Technology into its Product Formulation 14179 1Nuvilex Inc Announced that Reme Flu 28TM 29 will Incorporate Proprietary Syn X9 28TM 29 Delivery Technology into its Product Formulation 14179 2Nuvilex Inc Announced that Reme Flu 28TM 29 will Incorporate Proprietary Syn X9 28TM 29 Delivery Technology into its Product Formulation 14179 3
...armaceuticals, Inc.,(OTC Bulletin Board: ACCP) ann... using the company,s proprietary Cobalamin(TM) tec... an animal model of diabetes, through,its oral ins... Cobalamin,which is based upon the body,s natural ...tract, were tested in an animal model of diabetes....
...m 11 PROCRIT(R) (Epoetin alfa),studies will be pre... 49th,Annual Meeting and Exposition December 8 - 1...ghts including:, -- the potential impact on the n...ythropoiesis-stimulating agents (ESAs) for the tre...-- the use of PROCRIT in extended dosing regimens;...
Other Medicine Technology:Access Pharmaceuticals Demonstrates Ability to Significantly Reduce Glucose Levels in Pre-clinical Testing of Cobalamin(TM) Oral Insulin 2Access Pharmaceuticals Demonstrates Ability to Significantly Reduce Glucose Levels in Pre-clinical Testing of Cobalamin(TM) Oral Insulin 3PROCRIT(R) (Epoetin Alfa) Data to be Presented at American Society of Hematology Annual Meeting 2PROCRIT(R) (Epoetin Alfa) Data to be Presented at American Society of Hematology Annual Meeting 3PROCRIT(R) (Epoetin Alfa) Data to be Presented at American Society of Hematology Annual Meeting 4PROCRIT(R) (Epoetin Alfa) Data to be Presented at American Society of Hematology Annual Meeting 5PROCRIT(R) (Epoetin Alfa) Data to be Presented at American Society of Hematology Annual Meeting 6PROCRIT(R) (Epoetin Alfa) Data to be Presented at American Society of Hematology Annual Meeting 7PROCRIT(R) (Epoetin Alfa) Data to be Presented at American Society of Hematology Annual Meeting 8PROCRIT(R) (Epoetin Alfa) Data to be Presented at American Society of Hematology Annual Meeting 9
Optima III Noninsulated Allis Tooth Grasper, without ratchet
Optima III Noninsulated Duck-Bill Grasper, with ratchet
Uninsulated locking handle
Snap-In Snap-Out®-II Single Ring Handle, ratcheted, noninsulated handle, insulated shaft
Medicine Products: